Amniotic fluid embolism in pregnant women is pulmonary embolism, disseminated intravascular coagulation, etc. caused by amniotic fluid entering the maternal circulation during labor and delivery, and even life-threatening. The disease requires prompt resuscitation, such as correcting respiratory and circulatory failure, anti-allergy and anti-shock.
The etiology of amniotic fluid embolism in pregnant women is not yet clear, and it may be related to the opening of uterine blood sinuses, high pressure in the amniotic cavity, and rupture of fetal membranes. In addition, the risk of developing amniotic fluid embolism is increased by factors such as advanced primiparity, transient labor, macrosomia, and stillbirth.
Amniotic fluid embolism occurs in pregnant women between 2 hours before and 30 minutes after delivery, and is typically characterized by sudden onset of hypotension, hypoxemia, and coagulation disorders.
Pregnant women with amniotic fluid embolism should be treated promptly, e.g., mask oxygen, opium poppy hydrochloride, aminophylline, atropine, phentolamine, etc., as prescribed by the doctor.